Adaptive resistance in cancer immunotherapy.
Saved in:
| Title: | Adaptive resistance in cancer immunotherapy. |
|---|---|
| Authors: | Yang K; Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China. key@cqmu.edu.cn.; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. key@cqmu.edu.cn., Yang C; Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China., Xiong K; Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China., Hao J; Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China., Ye L; Institute of Immunology, Third Military Medical University, Chongqing, China. yelilinlcmv@tmmu.edu.cn.; Changping Laboratory, Beijing, China. yelilinlcmv@tmmu.edu.cn. |
| Source: | Cellular & molecular immunology [Cell Mol Immunol] 2026 Jul; Vol. 23 (7), pp. 743-772. Date of Electronic Publication: 2026 May 20. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Chinese Society of Immunology Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
